Remission of HIV-associated myelopathy after highly active antiretroviral therapy

Journal of Postgraduate Medicine

Volumn 50, Issue 3, 2004, Pages 195-196

  Fernández Fernández, Francisco Javier ^a   de la Fuente Aguado, J ^a   Ocampo Hermida, A ^a   Iglesias Castanon A ^a  

^a HOSPITAL XERAL CÍES   (Spain)

Author keywords

AIDS; HAART; HIV associated myelopathy

Indexed keywords

CD4 ANTIGEN; COTRIMOXAZOLE; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; RITONAVIR; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; FEMALE; GENERAL CONDITION IMPROVEMENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; REMISSION; SENSORY DYSFUNCTION; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; URINARY DYSFUNCTION;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; LAMIVUDINE; REMISSION, SPONTANEOUS; RITONAVIR; SPINAL CORD DISEASES; ZIDOVUDINE;

EID: 7444258581     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Tan SV, Guiloff RJ, Scaravilli F. AIDS-associated vacuolar myelopathy. A morphometric study. Brain 1995;118:1247-61.
2. Petito CK, Navia BA, Cho ES, Jordan BD, George DC, Price RW. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med 1985;312:874-9.
3. Staudinger R, Henry K. Remission of HIV myelopathy after highly active antiretroviral therapy. Neurology 2000;54:267-8.
4. Eyer-Silva WA, Auto I, Pinto JF, Morais-de-Sá CA. Myelopathy in a previously asymptomatic HIV-1-infected patient. Infection 2001;29:99-102.
5. Eyer-Silva WA, Couto-Fernandez JC, Caetano MR, Chequer-Fernandez SL, Pinto JF, Morais-de-Sá CA, et al. Remission of HIV-associated myelopathy after initiation of lopinavir in a patient with extensive previous exposure to highly active antiretroviral therapy. AIDS 2002;16:2367-9.
6. Di Rocco A, Tagliati M. Remission of HIV myelopathy after highly active antiretroviral therapy. Neurol 2000;55:456.
7. Dal Pan GJ, Glass JD, McArthur JC. Clinicopathologic correlations of HIV-1-associated vacuolar myelopathy: An autopsy-based case-control study. Neurol 1994;44:2159-64.
8. Artigas J, Grosse G, Niedobitek F. Vacuolar myelopathy in AIDS. A morphological analysis. Pathol Res Pract 1990;186:228-37.
9. Tan SV, Guiloff RJ. Hypothesis on the pathogenesis of vacuolar myelopathy, dementia and peripheral neuropathy in AIDS. J Neurol Neurosurg Psychiatry 1998;65:23-8.
10. Chong J, Di Rocco A, Tagliati M, Danisi F, Simpson DM, Atlas SW. MR findings in AIDS-associated myelopathy. Am J Neuroradiol 1999;20:1412-6.
11. Tagliati M, Di Rocco A, Danisi F, Simpson DM. The role of somatosensory evoked potentials in the diagnosis of AIDS-associated myelopathy. Neurol 2000;54:1477-82.
12. Di Rocco A. Diseases of the spinal cord in human immunodeficiency virus infection. Semin Neurol 1999;19:151-5.